NCT02652416View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 16, 2016

Primary Completion Date

December 9, 2016

Study Completion Date

December 9, 2016

Conditions
Healthy
Interventions
DRUG

BI 1026706

oral administration

DRUG

Placebo

placebo

Trial Locations (1)

812-0025

Souseikai Hakata Clinic, Fukuoka, Fukuoka

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY